Kangmei Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600518.SS

Kangmei Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 659.18 M

Kangmei Pharmaceutical Co., Ltd. Current Liabilities is USD 659.18 M for the year ending December 31, 2023, a -16.40% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Kangmei Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 788.53 M, a 1.29% change year over year.
Kangmei Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 778.49 M, a -78.18% change year over year.
Kangmei Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 3.57 B, a -10.71% change year over year.
Kangmei Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 4.00 B, a -3.45% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Shanghai Stock Exchange: 600518.SS

Kangmei Pharmaceutical Co., Ltd.

CEO	Mr. Guowei Liu
IPO Date	March 19, 2001
Location	China
Headquarters	East side of Jieshen Road
Employees	4,409
Sector	Healthcare
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical drug products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China.

Key trends

Past 5 years